Cryolife

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Cryolife ( CRY) is a biological medical device company. Cryolife preserves and distributes human tissues for transplantation and develops, manufactures, and commercializes medical devices for cardiac and vascular applications. This stock is trading up 8.4% at $5.78 in recent trading.

Today's Range: $5.54-$5.94

52-Week Range: $4.00-$6.02

Volume: 144,000

Three-Month Average Volume: 73,797

Shares of CRY are ripping higher today after the company reported earnings per share of 10 cents for the quarter, topping Wall Street estimates of 5 cents per share. The company's revenue for the quarter was up 12.9% on a year-over-year basis.

>>5 Stocks Under $10 Set to Soar

From a technical perspective, CRY is soaring higher here with above average volume. This move is quickly pushing the stock within range of triggering a major breakout trade. That trade will hit once CRY takes out some past overhead resistance levels at $6.02 to $6.17 with high volume.

Traders should now look for long-biased trades in CRY as long as it's trending above $5.45, and then once it sustains a move or close over $6.02 to $6.17 with volume that's near or above 73,797 shares. If we get that action soon, then CRY will have a great chance of re-testing and possibly taking out its next major overhead resistance levels at $6.79 to $7.45.

If you liked this article you might like

S&P 500, Dow and Nasdaq Post New Records as Crude Rallies

Wall Street on Track for Across-the-Board Records as Crude Rallies

How to Trade These Most Active Stocks -- LifeLock, Tyson Foods and More

Midday Report: 3M Drags on Dow After Downgrade; Crude Surges to Boost S&P 500

Stocks Trade Near Records as Crude Oil Surge Plateaus